News and Analysis

Helix scores $50m Series C

Helix, a population genomics and COVID-19 testing company, has raised $50 million in Series C funding.

-

Helix, a population genomics and COVID-19 testing company, has raised $50 million in Series C funding. Warburg Pincus, DFJ Growth, Kleiner Perkins Caufield Byers, Mayo Clinic and Temasek led the round.

Source: Press Release